New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Phathom Pharmaceuticals, Inc.
PHAT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

272M

Biotechnology

Next Earning date - 08 May 2025

272M

Biotechnology

Next Earning date - 08 May 2025

3.90USD

Shape-0.13 ( -3.23%)
moonAfter-hours 4.19$arrow-right-up0.29 (7.44%)
Market Closed (as of Apr 21, 20:00 EDT)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-1%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

80%

Quote Panel

Shape
Updated April 21, 2025
1W -18.24 % 1M -40.46 % 3M -44.21 % 1Y -56.71 %

Key Metrics

Shape
  • Market Cap

    271.58M


  • Shares Outstanding

    69.64M


  • Share in Float

    38.70M


  • Dividende

    0


  • Earning Date

    08 May 2025


  • Price Target

    3.9


  • Average Volume

    1.21M


  • Beta

    0.351


  • Range

    3.81-19.71


  • Industry

    Biotechnology


  • Website

    https://www.phathompharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.92x

P/S Ratio

-1.09x

P/B Ratio

-0.8

Debt/Equity

-605.1%

Net Margin

$-5.3

EPS

How PHAT compares to sector?

P/E Ratio

Relative Strength

Shape

PHAT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.89
vs -1.07

Q2.23

arrow
arrow

N/A

-0.84
vs -1.33

Q3.23

arrow
arrow

N/A

-0.76
vs -1.32

Q4.23

arrow
arrow

N/A

-0.80
vs -1.33

Q1.24

arrow
arrow

N/A

-1.42
vs -0.89

Q2.24

arrow
arrow

N/A

-1.25
vs -0.84

Q3.24

arrow
arrow

N/A

-1.32
vs -0.76

Q4.24

arrow
arrow

N/A

-0.79
vs -0.80

Q1.25

arrow
arrow

N/A

-1.10
vs -1.42

Q2.25

arrow
arrow

N/A

-1.03
vs -1.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

682K  vs NA

Q1.24

arrow
arrow

NA

1.9M  vs NA

Q2.24

arrow
arrow

NA

7.3M  vs NA

Q3.24

arrow
arrow

NA

16.4M  vs NA

Q4.24

arrow
arrow

+4250%

29.7M  vs 682K

Q1.25

arrow
arrow

+1433%

29.3M  vs 1.9M

Q2.25

arrow
arrow

+416%

37.8M  vs 7.3M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+42%

0.42
vs 0.85

Q2.23

arrow
arrow

-233%

-2.33
vs 0.42

Q3.23

arrow
arrow

+243%

2.43
vs -2.33

Q4.23

arrow
arrow

+109%

1.09
vs 2.43

Q1.24

arrow
arrow

+56%

0.56
vs 1.09

Q2.24

arrow
arrow

+39%

0.39
vs 0.56

Q3.24

arrow
arrow

+46%

0.46
vs 0.39

Q4.24

arrow
arrow

+29%

0.29
vs 0.46

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

87

87
vs 88

-1%

Q2.23

arrow
arrow

108

108
vs 87

24%

Q3.23

arrow
arrow

113

113
vs 108

5%

Q4.23

arrow
arrow

121

121
vs 113

7%

Q1.24

arrow
arrow

118

118
vs 121

-2%

Q2.24

arrow
arrow

117

117
vs 118

-1%

Q3.24

arrow
arrow

138

138
vs 117

18%

Q4.24

arrow
arrow

148

148
vs 138

7%

Earnings Growth

Latest News